Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cellectar Biosc (NQ: CLRB )

0.8995 USD -0.0206 (-2.24%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 322,045
Open 0.9115
Bid (Size) 0.8950 (2)
Ask (Size) 0.9200 (20)
Prev. Close 0.9201
Today's Range 0.8733 - 0.9199
52wk Range 0.8100 - 2.980
Shares Outstanding 61,101,264
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Preliminary Data with Iopofosine I-131 in Combination with External Beam Radiation Suggests Safety and Tolerability in Relapsed or Refractory Head and Neck Cancer
Initiation of Expansion Cohort of Up to 24 Patients 
From GlobeNewswire News Releases
Cellectar to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
From GlobeNewswire News Releases

Performance

YTD
-56.55%
-56.55%
1 Month
-8.21%
-8.21%
3 Month
-17.48%
-17.48%
6 Month
-43.43%
-43.43%
1 Year
-26.27%
-26.27%

More News

Read More
Cellectar Awarded $2.0 Million Phase II NIH SBIR Grant to Support Pivotal Study of Iopofosine I-131 in Waldenstrom’s Macroglobulinemia
From GlobeNewswire News Releases
Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131
From GlobeNewswire News Releases
Cellectar Reports Financial Results for the Second Quarter 2021 and Provides a Corporate Update
From GlobeNewswire News Releases
Cellectar Announces Expansion of Ongoing Collaboration Agreement with IntoCell Inc.
From GlobeNewswire News Releases
Cellectar Bio's Iopofosine Data Shows Favorable Safety Profile In Head & Neck Cancer
Tags Briefs General CLRB
From Benzinga
Cellectar Announces a Co-Development and Commercialization Collaboration with LegoChemBio for New Small Molecule Phospholipid Drug Conjugates (PDCs)
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tags IPHA BZI/TFM PROG
From Benzinga
4 Penny Stocks Insiders Are Buying
Tags Penny Stocks Penny Stocks Insider Buying SHRG
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tags BZI/TFM ITRM ATNF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]